Bachem Holding AG

BANB

Company Profile

  • Business description

    Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and USA. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.

  • Contact

    Hauptstrasse 144
    Bubendorf4416
    CHE

    T: +41 585952021

    E: [email protected]

    https://www.bachem.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Chemicals

    Fiscal Year End

    31 December 2025

    Employees

    2,292

Stocks News & Analysis

stocks

ASX reporting season wrap: BHP, banks, CSL bloodbath and more

A round up of notable stories and reactions as ASX earnings season continues.
stocks

Stock showdown: How do ASX healthcare giants compare on key investing criteria?

Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
stocks

Peak profit for ASX listed insurer

Simplification plan complete, organic growth now the focus.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,234.3055.70-0.60%
CAC 407,969.6931.400.40%
DAX 4024,363.0969.750.29%
Dow JONES (US)45,631.74846.241.89%
FTSE 1009,321.4012.200.13%
HKSE25,339.14234.530.93%
NASDAQ21,496.54396.221.88%
Nikkei 22542,633.2923.120.05%
NZX 50 Index13,042.76151.31-1.15%
S&P 5006,466.9196.741.52%
S&P/ASX 2008,967.4057.00-0.63%
SSE Composite Index3,825.7654.661.45%

Market Movers